IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity

References

• Jakobisiak M, Golab J, Lasek W. Interleukin 15 as a promising candidate for tumor immunotherapy. Cytokine Growth Factor Rev 2011; 22:99-108; PMID:21531164; http://dx.doi.org/10.1016/j.cytogfr.2011.04.001
   PubMed Web of Science ®Google Scholar
• van Heel DA. Interleukin 15: its role in intestinal inflammation. Gut 2006; 55:444-5; PMID:16531523; http://dx.doi.org/10.1136/gut.2005.079335
   PubMed Web of Science ®Google Scholar
• Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996; 156:735-41
   PubMed Web of Science ®Google Scholar
• Schulthess J, Meresse B, Ramiro-Puig E, Montcuquet N, Darche S, Begue B, Ruemmele F, CombadiÈre C, Di Santo JP, Buzoni-Gatel D et al. Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity 2012; 37:108-21; PMID:22705105; http://dx.doi.org/10.1016/j.immuni.2012.05.013
   PubMed Web of Science ®Google Scholar
• Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994; 13:2822-30; PMID:8026467
   PubMed Web of Science ®Google Scholar
• Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994; 264:965-8; PMID:8178155; http://dx.doi.org/10.1126/science.8178155
   PubMed Web of Science ®Google Scholar
• Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994; 91:4940-4; PMID:8197161; http://dx.doi.org/10.1073/pnas.91.11.4940
   PubMed Web of Science ®Google Scholar
• Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002; 17:537-47; PMID:12433361; http://dx.doi.org/10.1016/S1074-7613(02)00429-6
   PubMed Web of Science ®Google Scholar
• Castillo EF, Schluns KS. Regulating the immune system via IL-15 transpresentation. Cytokine 2012; 59:479-90; PMID:22795955; http://dx.doi.org/10.1016/j.cyto.2012.06.017
   PubMed Web of Science ®Google Scholar
• Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191:771-80; PMID:10704459; http://dx.doi.org/10.1084/jem.191.5.771
   PubMed Web of Science ®Google Scholar
• Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9:669-76; PMID:9846488; http://dx.doi.org/10.1016/S1074-7613(00)80664-0
   PubMed Web of Science ®Google Scholar
• Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM et al. Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias. Cancer Res 2009; 69:3986-94; PMID:19366803; http://dx.doi.org/10.1158/0008-5472.CAN-08-3735
   PubMed Web of Science ®Google Scholar
• Shah MV, Zhang R, Irby R, Kothapalli R, Liu X, Arrington T, Frank B, Lee NH, Loughran TP Jr. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 2008; 112:770-81; PMID:18477771; http://dx.doi.org/10.1182/blood-2007-11-121871
   PubMed Web of Science ®Google Scholar
• Kuniyasu H, Ohmori H, Sasaki T, Sasahira T, Yoshida K, Kitadai Y, Fidler IJ. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Clin Cancer Res 2003; 9:4802-10; PMID:14581351
   PubMed Web of Science ®Google Scholar
• Trentin L, Cerutti A, Zambello R, Sancretta R, Tassinari C, Facco M, Adami F, Rodeghiero F, Agostini C, Semenzato G. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood 1996; 87:3327-35; PMID:8605349
   PubMed Web of Science ®Google Scholar
• Kuniyasu H, Oue N, Nakae D, Tsutsumi M, Denda A, Tsujiuchi T, Yokozaki H, Yasui W. Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology 2001; 69:86-95; PMID:11752902; http://dx.doi.org/10.1159/000048761
   PubMed Web of Science ®Google Scholar
• Mishra A, Liu S, Sams GH, Curphey DP, Santhanam R, Rush LJ, Schaefer D, Falkenberg LG, Sullivan L, Jaroncyk L et al. Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation. Cancer Cell 2012; 22:645-55; PMID:23153537; http://dx.doi.org/10.1016/j.ccr.2012.09.009
   PubMed Web of Science ®Google Scholar
• Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol 2012; 35:229-44; PMID:23161445; http://dx.doi.org/10.1007/s00281-012-0352-6
   PubMed Web of Science ®Google Scholar
• Wang K, Grivennikov SI, Karin M. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases. Ann Rheum Dis 2013; 72 Suppl 2:ii100-3; PMID:23253923; http://dx.doi.org/10.1136/annrheumdis-2012-202201
   PubMed Web of Science ®Google Scholar
• Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, Rickman BH, Rogers AB, Moroski-Erkul CA, McFaline JL et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008; 118:2516-25; PMID:18521188; http://dx.doi.org/10.1172/jci35073
   PubMed Web of Science ®Google Scholar
• Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL, Mobley M, Ge Z et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A 2012; 109:E1820-9; PMID:22689960; http://dx.doi.org/10.1073/pnas.1207829109
   PubMed Web of Science ®Google Scholar
• Bondurant KL, Lundgreen A, Herrick JS, Kadlubar S, Wolff RK, Slattery ML. Interleukin genes and associations with colon and rectal cancer risk and overall survival. Inter J Cancer 2013; 132:905-15; PMID:22674296; http://dx.doi.org/10.1002/ijc.27660
   PubMed Web of Science ®Google Scholar
• Graziano F, Ruzzo A, Canestrari E, Loupakis F, Santini D, Rulli E, Humar B, Galluccio N, Bisonni R, Floriani I et al. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. Pharmacogenomics J 2009; 9:78-84; PMID:19104506; http://dx.doi.org/10.1038/tpj.2008.16
   PubMed Web of Science ®Google Scholar
• Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ et al. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer. Pharmacogenetics Genomics 2009; 19:95-102; PMID:18987561; http://dx.doi.org/10.1097/FPC.0b013e32831a9ad1
   PubMed Web of Science ®Google Scholar
• Nieminen U, Jussila A, Nordling S, Mustonen H, Farkkila MA. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data. Int J Cancer 2014; 134:189-96; PMID:23797639; http://dx.doi.org/10.1002/ijc.28346
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13:759-71; PMID:24154716; http://dx.doi.org/10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996; 39:87-92; PMID:8881816; http://dx.doi.org/10.1136/gut.39.1.87
   PubMed Web of Science ®Google Scholar
• Neufert C, Becker C, Neurath MF. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2007; 2:1998-2004; PMID:17703211; http://dx.doi.org/10.1038/nprot.2007.279
   PubMed Web of Science ®Google Scholar
• Obermeier F, Hausmann M, Kellermeier S, Kiessling S, Strauch UG, Duitman E, Bulfone-Paus S, Herfarth H, Bock J, Dunger N et al. IL-15 protects intestinal epithelial cells. Eur J Immunol 2006; 36:2691-9; PMID:16981178; http://dx.doi.org/10.1002/eji.200535173
   PubMed Web of Science ®Google Scholar
• Steel JC, Waldmann TA, Morris JC. Interleukin-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci 2012; 33:35-41; PMID:22032984; http://dx.doi.org/10.1016/j.tips.2011.09.004
   PubMed Web of Science ®Google Scholar
• Ochoa MC, Fioravanti J, Rodriguez I, Hervas-Stubbs S, Azpilikueta A, Mazzolini G, Gúrpide A, Prieto J, Pardo J, Berraondo P et al. Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein. Cancer Res 2013; 73:139-49; PMID:23149919; http://dx.doi.org/10.1158/0008-5472.CAN-12-2660
   PubMed Web of Science ®Google Scholar
• Zhang M, Yao Z, Dubois S, Ju W, Muller JR, Waldmann TA. Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. Proc Natl Acad Sci U S A 2009; 106:7513-8; PMID:19383782; http://dx.doi.org/10.1073/pnas.0902637106
   PubMed Web of Science ®Google Scholar
• Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, Waldmann TA, Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A 2000; 97:11445-50; PMID:11016962; http://dx.doi.org/10.1073/pnas.200363097
   PubMed Web of Science ®Google Scholar
• Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996; 111:1706-13; PMID:8942753; http://dx.doi.org/10.1016/S0016-5085(96)70036-7
   PubMed Web of Science ®Google Scholar
• Nishimura H, Fujimoto A, Tamura N, Yajima T, Wajjwalku W, Yoshikai Y. A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing. FASEB J 2005; 19:19-28; PMID:15629891; http://dx.doi.org/10.1096/fj.04-2633com
   PubMed Web of Science ®Google Scholar
• Chen J, Huang XF. The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol Ther 2009; 8:1313-7; PMID:19502780; http://dx.doi.org/10.4161/cbt.8.14.8983
   PubMed Web of Science ®Google Scholar
• Gomez-Nicola D, Spagnolo A, Guaza C, Nieto-Sampedro M. Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice. Exp Neurol 2010; 222:235-42; PMID:20070942; http://dx.doi.org/10.1016/j.expneurol.2009.12.034
   PubMed Web of Science ®Google Scholar
• Rauch DA, Harding JC, Ratner L. IL-15 deficient tax mice reveal a role for IL-1alpha in tumor immunity. PloS One 2014; 9:e85028; PMID:24416335; http://dx.doi.org/10.1371/journal.pone.0085028
   PubMedGoogle Scholar
• Yoshihara K, Yajima T, Kubo C, Yoshikai Y. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 2006; 55:334-41; PMID:16162679; http://dx.doi.org/10.1136/gut.2005.076000
   PubMed Web of Science ®Google Scholar
• Yu P, Steel JC, Zhang M, Morris JC, Waldmann TA. Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin Cancer Res 2010; 16:6019-28; PMID:20924130; http://dx.doi.org/10.1158/1078-0432.CCR-10-1966
   PubMed Web of Science ®Google Scholar
• Nishiyama R, Sakaguchi T, Kinugasa T, Gu X, MacDermott RP, Podolsky DK, Reinecker HC. Interleukin-2 receptor beta subunit-dependent and -independent regulation of intestinal epithelial tight junctions. J Biol Chem 2001; 276:35571-80; PMID:11466322; http://dx.doi.org/10.1074/jbc.M106013200
   PubMed Web of Science ®Google Scholar
• Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA, Goldrath AW, Turley SJ. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res 2008; 68:2972-83; PMID:18413767; http://dx.doi.org/10.1158/0008-5472.CAN-08-0045
   PubMed Web of Science ®Google Scholar
• Davies E, Reid S, Medina MF, Lichty B, Ashkar AA. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells. J Leukocyte Biol 2010; 88:529-36; PMID:20538758; http://dx.doi.org/10.1189/jlb.0909648
   PubMed Web of Science ®Google Scholar
• Gillgrass A, Gill N, Babian A, Ashkar AA. The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages. J Immunol 2014; 193:6184-91; PMID:25355926; http://dx.doi.org/10.4049/jimmunol.1303175
   PubMed Web of Science ®Google Scholar
• Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464:1371-5; PMID:20393462; http://dx.doi.org/10.1038/nature08949
   PubMed Web of Science ®Google Scholar
• Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101:2620-7; PMID:12411307; http://dx.doi.org/10.1182/blood-2002-05-1461
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008; 118:534-44; PMID:18172556; http://dx.doi.org/10.1172/jci33194
   PubMed Web of Science ®Google Scholar
• Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005; 129:969-84; PMID:16143135; http://dx.doi.org/10.1053/j.gastro.2005.06.071
   PubMed Web of Science ®Google Scholar
• Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210:917-31; PMID:23589566; http://dx.doi.org/10.1084/jem.20122308
   PubMed Web of Science ®Google Scholar
• Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, PagÈs F et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; http://dx.doi.org/10.1158/0008-5472.CAN-10-2907
   PubMed Web of Science ®Google Scholar
• Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15:1016-22; PMID:19701202; http://dx.doi.org/10.1038/nm.2015
   PubMed Web of Science ®Google Scholar
• Perera LP, Goldman CK, Waldmann TA. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol 1999; 162:2606-12; PMID:10072502
   PubMed Web of Science ®Google Scholar
• Chen JP, Liao NS, Lai SL, Hsu L, Mao WY, Ku MC, Liao F. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression. Eur J Immunol 2005; 35:690-8; PMID:15719370; http://dx.doi.org/10.1002/eji.200425577
   PubMed Web of Science ®Google Scholar
• Chenoweth MJ, Mian MF, Barra NG, Alain T, Sonenberg N, Bramson J, Lichty BD, Richards CD, Ma A, Ashkar AA. IL-15 can signal via IL-15Ralpha, JNK, and NF-kappaB to drive RANTES production by myeloid cells. J Immunol 2012; 188:4149-57; PMID:22447977; http://dx.doi.org/10.4049/jimmunol.1101883
   PubMed Web of Science ®Google Scholar
• Lavergne E, Combadiere C, Iga M, Boissonnas A, Bonduelle O, Maho M, DebrÉ P, Combadiere B. Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration. J Iimmunol 2004; 173:3755-62; PMID:15356122; http://dx.doi.org/10.4049/jimmunol.173.6.3755
   PubMed Web of Science ®Google Scholar
• Nesbeth Y, Scarlett U, Cubillos-Ruiz J, Martinez D, Engle X, Turk MJ, Conejo-Garcia JR. CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion. Cancer Res 2009; 69:6331-8; PMID:19602595; http://dx.doi.org/10.1158/0008-5472.CAN-08-4329
   PubMed Web of Science ®Google Scholar
• DePaolo RW, Abadie V, Tang F, Fehlner-Peach H, Hall JA, Wang W, Marietta EV, Kasarda DD, Waldmann TA, Murray JA et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 2011; 471:220-4; PMID:21307853; http://dx.doi.org/10.1038/nature09849
   PubMed Web of Science ®Google Scholar
• Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT. Chemokines in human colorectal carcinoma. Anticancer Res 2005; 25:3581-4; PMID:16101183
   PubMed Web of Science ®Google Scholar
• Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140:1807-16; PMID:21530747; http://dx.doi.org/10.1053/j.gastro.2011.01.057
   PubMed Web of Science ®Google Scholar
• Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005; 434:907-13; PMID:15829965; http://dx.doi.org/10.1038/nature03485
   PubMed Web of Science ®Google Scholar
• Cooks T, Pateras IS, Tarcic O, Solomon H, Schetter AJ, Wilder S, Lozano G, Pikarsky E, Forshew T, Rosenfeld N et al. Mutant p53 prolongs NF-kappaB activation and promotes chronic inflammation and inflammation-associated colorectal cancer. Cancer Cell 2013; 23:634-46; PMID:23680148; http://dx.doi.org/10.1016/j.ccr.2013.03.022
   PubMed Web of Science ®Google Scholar
• Schramek D, Kotsinas A, Meixner A, Wada T, Elling U, Pospisilik JA, Neely GG, Zwick RH, Sigl V, Forni G et al. The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression. Nat Genet 2011; 43:212-9; PMID:21317887; http://dx.doi.org/10.1038/ng.767
   PubMed Web of Science ®Google Scholar
• Kotsinas A, Evangelou K, Zacharatos P, Kittas C, Gorgoulis VG. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. Am J Pathol 2002; 161:1619-34; PMID:12414510; http://dx.doi.org/10.1016/S0002-9440(10)64440-9
   PubMed Web of Science ®Google Scholar
• Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG, Nebreda AR. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell 2014; 25:484-500; PMID:24684847; http://dx.doi.org/10.1016/j.ccr.2014.02.019
   PubMed Web of Science ®Google Scholar